Darya-Varia Laboratoria Tbk PT
IDX:DVLA

Watchlist Manager
Darya-Varia Laboratoria Tbk PT Logo
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Watchlist
Price: 1 635 IDR 0.31% Market Closed
Market Cap: 1.8T IDR
Have any thoughts about
Darya-Varia Laboratoria Tbk PT?
Write Note

Darya-Varia Laboratoria Tbk PT
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Darya-Varia Laboratoria Tbk PT
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Capital Expenditures
-Rp111.8B
CAGR 3-Years
-3%
CAGR 5-Years
-18%
CAGR 10-Years
-9%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Capital Expenditures
-Rp379.4B
CAGR 3-Years
5%
CAGR 5-Years
-3%
CAGR 10-Years
3%
Kalbe Farma Tbk PT
IDX:KLBF
Capital Expenditures
-Rp1.4T
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
-5%
Soho Global Health Tbk PT
IDX:SOHO
Capital Expenditures
-Rp55.6B
CAGR 3-Years
4%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Capital Expenditures
-Rp20.8B
CAGR 3-Years
8%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Capital Expenditures
-Rp494.6B
CAGR 3-Years
0%
CAGR 5-Years
12%
CAGR 10-Years
-20%
No Stocks Found

Darya-Varia Laboratoria Tbk PT
Glance View

Market Cap
1.8T IDR
Industry
Pharmaceuticals

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trade of pharmaceutical products and cosmetics. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,274 full-time employees. Its segments include prescription drugs, consumer health products, and export and toll manufacturing services. The firm provides products and services for consumer health, skin nutrition, respiratory, vitamins and daily relief. The Company’s products include Remscar (silicone gel), Carvilol, Ondavar (antiemetic), Etorix, Forti-D (vitamin D supplement), Decolgen, Neozep, Stop Cold, Decolsin, and Allerin. The Carvilol is used for heart health and treating hypertension. Ondavar is an antiemetic product used for nausea and vomiting during pregnancy. Etorix is a pain reliever. Forti-D is a supplement to fulfill the body’s need for vitamin D3. Darya-Varia provides a range of brands such as Enervon-C, Enervon Active, and Supertin that helps to boost body immune and maintain health. The firm also provides Imunped as supplement for kids with Zinc and vitamin C for children.

DVLA Intrinsic Value
2 178.44 IDR
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Darya-Varia Laboratoria Tbk PT's Capital Expenditures?
Capital Expenditures
-111.8B IDR

Based on the financial report for Sep 30, 2024, Darya-Varia Laboratoria Tbk PT's Capital Expenditures amounts to -111.8B IDR.

What is Darya-Varia Laboratoria Tbk PT's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-9%

Over the last year, the Capital Expenditures growth was -48%. The average annual Capital Expenditures growth rates for Darya-Varia Laboratoria Tbk PT have been -3% over the past three years , -18% over the past five years , and -9% over the past ten years .

Back to Top